On the basis of applications, the implantable
drug delivery devices market is segmented as: Cardiovascular, ophthalmology, contraception/birth control, oncology, and others (diabetes and chronic pain conditions).
hearing device for sensorineural hearing loss.
Core Manufacturing provides manufacturing capabilities for active implantable
devices, its outsourcing capabilities include rapid-turn prototyping, full turn-key assembly and testing, and sterilization, inspection and metrology for active implantable
Mann added: ``While the current trial is not yet evaluating automatic control of insulin delivery in humans, the sensor is connected to the implantable
pump, which has been extensively validated in over 600 patients over almost 10 years.
In the largest and most definitive study yet of people fitted with implantable
defibrillators, researchers at Stanford University Medical School have found that nearly 60 percent of these patients survived at least 10 years with the device -- an overall survival rate that Watkins terms "extraordinary.
Microassembly and micropackaging of implantable
As the implantable
device market continues to grow, the health care industry is looking for solutions.
Renub Research study titled "Global Cardiac Implant Devices (Implantable
Cardioverter Defibrillators, Implantable
Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device) Market Forecast, Clinical Trials, M&A" provides a comprehensive assessment of the fast-evolving, high-growth global cardiac implant market.
GlobalData's new report, "Implantable
Cardioverter Defibrillators and Cardiac Resynchronization Therapy-Defibrillators - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global implantable
cardioverter defibrillators and cardiac resynchronization therapy defibrillators market.
The global implantable
drug delivery devices market is segmented into the following categories:
Stay ahead of the information curve in the fast changing Implantable
Cardioverter Defibrillator market.
performed the first and second AbioCor implantable
replacement heart procedures in the world and a total of seven implants since 2001.